
Diabetes
Latest News
CME Content





Scientists from the Diabetes Research Centre at the University of Leicester have identified a link between low blood glucose levels and adverse cardiovascular events in patients with diabetes.

Researchers are calling for updated diabetes prevention guidelines that incorporate fetal experiences into the risk equation.

In a large, international study, pioglitazone (Actos) and rosiglitazone (Avandia) did not lead to an increased risk for bladder cancer, contradicting previous studies that suggested the opposite.

The FDA has approved the Animas Vibe insulin pump and continuous glucose monitoring system for the management of insulin-requiring diabetic adults.

Although hypertension and diabetes are often comorbid conditions, nearly one-third of hypertensive patients have not had their blood sugar tested in the last 3 years.

Dantrolene found to help prevent the destruction of insulin-producing beta cells in patients with Wolfram syndrome.

Excess medical costs for diabetes and lost productivity amounted to more than $322 billion in 2012, a 48% increase from the $218 billion estimate for 2007.


Patients with type 2 diabetes mellitus may see a reduction in blood sugar levels and body weight with empagliflozin treatment, according to data from Eli Lilly and Company and Boehringer Ingelheim Pharmaceuticals Inc.

Implementing eye screening via telemedicine among patients with diabetes uncovered that 1 in 5 have diabetic retinopathy.




When trimethoprim/sulfamethoxazole is concomitantly administered with other potassium-sparing diuretics or inhibitors of the renin-angiotensin system, drug interaction notifications alert pharmacists to the potential of hyperkalemia.

A novel SMS platform initially designed to help people manage diabetes helps to warn the public.

Treating patients with type 2 diabetes mellitus just got a little easier.

A potential Ebola outbreak in Senegal was snuffed out thanks in part to an innovative text-messaging program originally intended to help patients with diabetes manage their disease.


The new Diabetes Health Coach creates a personalized experience designed to help people living with diabetes improve their diabetes management.

The City of Houston and Novo Nordisk today announced an innovative partnership to fight the urban diabetes epidemic. Houston is the third city globally and the first in the United States to join the Cities Changing Diabetes programme, which was initiated earlier in 2014 by Novo Nordisk. The first two cities are Mexico City and Copenhagen.

The dangers of failing to change the clocks on insulin pumps in recognition of daylight saving time.



































































































